Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C in Autologous Stem Cell Transplantations
NCT03964688Phase 2Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Dec 2019
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in multiple myeloma (MM) and lymphoma comparing Vitamin C with Placebo (2 arms). Primary endpoint: Immune recovery. Started Dec 2019; status: completed.
02
Drugs
ascorbic acid
03
Conditions
multiple myeloma (MM)lymphoma
Beyond the preview
Go deeper on NCT03964688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03964688.